Key result
ICD implantation rates varied across Western Europe and negatively correlated with amiodarone use, while patient age at implantation increased from 1993 to 1998.
Observational (n=2,257)
Yes
Answers are grounded in this paper and cite their sources.
ICD implantation rates in Western Europe between 1993 and 1998 varied widely and were inversely correlated with amiodarone use, rather than being driven by healthcare expenditure.
Despite the demonstrated efficacy of implantable cardioverter defibrillators (ICDs) in reducing sudden and total mortality in selected populations, their implantation rates vary greatly between countries. The aim of our study was to analyze temporal and geographical trends in ICD implantations in countries with similar health related expenditure in Western Europe. A total of 2,257 patients from ten European evaluation studies of Medtronic defibrillators and defibrillation electrodes, conducted between 1993 and 1998, representing 12 countries, was included in this analysis. Rates of implantation and clinical characteristics were compared between countries and years of implantation. Rates of implantation differed greatly between Western European countries and did not correlate with indices of health related expenditure (i.e., number of patients per physician and number of patients per hospital bed). However, there was a strong and statistically significant negative correlation between the use of amiodarone and the rates of implantation (r = -0.66, P = 0.02). Temporal trends showed a significant increase in the age of the patients receiving an ICD between 1993 and 1998 (57 +/- 14 vs 61 +/- 12 years, mean +/- SD, P < 0.001). There was also a temporal trend towards an increased incidence of coronary artery disease and a significant decrease in the incidence of cardiomyopathy. There was a temporal increase in implantations in patients with a history of ventricular tachycardia. Despite a general scientific agreement that ICDs are a first line treatment for patients at high risk of sudden cardiac death, their acceptance remains low in several developed countries. This low acceptance may not be entirely related to budget constraint but may also be related to their perceived efficacy by physicians and health authorities.
No takes yet. Share an insight, caveat, or question.
Copie et al. (2000) conducted an observational in High risk of sudden cardiac death (n=2,257). Implantable cardioverter defibrillators (ICDs) was evaluated on Temporal and geographical trends in ICD implantations (r = -0.66, p=0.02). ICD implantation rates varied across Western Europe and negatively correlated with amiodarone use, while patient age at implantation increased from 1993 to 1998.
Synapse has enriched 10 related papers. Consider them for comparative context: